Which imaging modalities are used to diagnose a solitary fibrous tumor of the pleura?

Which imaging modalities are used to diagnose a solitary fibrous tumor of the pleura?

• A. CXR and CT
• B. MRI
• C. Ultrasound
• D. PET-CT

Answer: (A)

When evaluating a solitary fibrous tumor of the pleura, start with chest imaging that can detect the mass and define its anatomic relationships. A chest radiograph often reveals a unilateral, well-circumscribed pleural-based mass and is typically the first clue. Computed tomography is the most informative next step. It provides detailed anatomy: a well-defined mass arising from the pleura, often with a pedicle or broad-based attachment, and it shows size, contour, enhancement after contrast, and adjacency or invasion of nearby structures such as the chest wall or ribs. CT helps distinguish benign-appearing, slow-growing lesions from features suggestive of malignancy, guiding surgical planning. MRI can be useful when there’s a need for superior soft-tissue contrast to assess chest wall or diaphragmatic involvement or complex relationships, especially in surgical planning. PET-CT is not a primary diagnostic tool for SFTP; it may be used to evaluate metabolic activity if malignancy is suspected or for staging. Ultrasound has limited utility for intrathoracic pleural tumors, though it can help assess pleural effusions or peripheral aspects in some cases. Thus, chest X-ray and CT are the imaging modalities most used to diagnose a solitary fibrous tumor of the pleura.

When evaluating a solitary fibrous tumor of the pleura, start with chest imaging that can detect the mass and define its anatomic relationships. A chest radiograph often reveals a unilateral, well-circumscribed pleural-based mass and is typically the first clue.

Computed tomography is the most informative next step. It provides detailed anatomy: a well-defined mass arising from the pleura, often with a pedicle or broad-based attachment, and it shows size, contour, enhancement after contrast, and adjacency or invasion of nearby structures such as the chest wall or ribs. CT helps distinguish benign-appearing, slow-growing lesions from features suggestive of malignancy, guiding surgical planning.

MRI can be useful when there’s a need for superior soft-tissue contrast to assess chest wall or diaphragmatic involvement or complex relationships, especially in surgical planning. PET-CT is not a primary diagnostic tool for SFTP; it may be used to evaluate metabolic activity if malignancy is suspected or for staging. Ultrasound has limited utility for intrathoracic pleural tumors, though it can help assess pleural effusions or peripheral aspects in some cases.

Thus, chest X-ray and CT are the imaging modalities most used to diagnose a solitary fibrous tumor of the pleura.